Search - tctmd.com

Displaying 341 - 360 of 1993

Sort: Relevancy | Date

Presentation TCT 2023

TCT 68: Cardiac Implantable Electronic Device Lead-Related Tricuspid Regurgitation in Patients Presenting for Transcatheter Tricuspid Valve Interventions

Presenter: Baban Kumar

October 26, 2023

Presentation TCT 2023

TCT 597: Transcatheter Tricuspid Valve Replacement: From Preclinical to Early First-in-Human Experiences with the MonarQ Device

Presenter: Arshad Quadri

October 26, 2023

Presentation TCT 2023

Can We Do Better? Next Generation LAAO Devices

Presenter: Saibal Kar

October 26, 2023

Presentation TCT 2023

TCT 614: Successful treatment of MAC patients with atrial fixation TMVR device: The AltaValve

Presenter: Philippe Genereux

October 26, 2023

Presentation TCT 2023

No: The Transcatheter Devices Have Much Better Results

Presenter: Torsten Vahl

October 26, 2023

Presentation TCT 2023

TCT 378: A novel miRNA nanocarrier for local device-based pharmacotherapy

Presenter: Stephanie Bettink

October 26, 2023

Presentation TCT 2023

Topic 4: Pulmonary Hypertension and Device Choice

Presenter: Neil Fam

October 26, 2023

Presentation TCT 2023

Topic 1: Atrial Functional TR and Device Choice

Presenter: Jörg Hausleiter

October 26, 2023

Presentation TCT 2023

TCT 846: First-in-Human Treatment of Severe Tricuspid Regurgitation using a novel Cross-Caval Heterotopic Device

Presenter: Rodrigo Estevez-Loureiro

October 26, 2023

Presentation TCT 2023

A Novel Heterotopic Tricuspid Regurgitation Device for the Treatment of Tricuspid Regurgitation (Innoventric)

Presenter: Philipp Lurz

October 25, 2023

Presentation TCT 2023

Other PFO Closure Devices and Techniques on the Horizon

Presenter: Sameer Gafoor

October 25, 2023

Presentation TCT 2023

TCT 888: Percutaneous catheter aspiration of native mitral valve endocarditis with brain protection using a new generation cerebral protection device

Presenter: Felix Hofmann

October 25, 2023

Presentation TCT 2023

TCT 465: PROTEMBO C-TRIAL: Evaluation of a Novel Cerebral Embolic Protection Device in TAVR

Presenter: Darren Mylotte

October 25, 2023

Presentation TCT 2023

TCT 945: Conform WhenThings are Unconformable: Novel Utilization of Combined Thrombectomy Devices to remove a Massive Organized Clot-in-Transit

Presenter: Mohammad Akram Kawsara

October 25, 2023

Presentation TCT 2023

PROs Alone in Non-Blinded Studies Shouldn’t Drive Device Approval

Presenter: Nir Uriel

October 25, 2023

Presentation TCT 2023

TCT 94: ProtEmbo: A Potential Shield Against Stroke and Cerebral Lesions in TAVR; Illustrated Using DW-MRI to Assess Device Efficacy

Presenter: Tobias Schmidt

October 25, 2023

Presentation TCT 2023

TCT 71: The Outcomes of Percutaneous Mitral Annuloplasty With the Carillon Device: Retrospective Analysis of Implanted vs Non-implanted Patients

Presenter: Tomasz Siminiak

October 25, 2023

Presentation TCT 2023

TCT 70: Comparison of the Outcomes of Mitral Annuloplasty With the Carillon Device in Patients With Proportionate and Disproportionate Functional Mitral Regurgitation

Presenter: Tomasz Siminiak

October 25, 2023

News Conference News TCT 2023

More TRILUMINATE Patients Flesh Out Tricuspid TEER’s Impact

Yael L. Maxwell

October 24, 2023

Presentation TCT 2023

Case: Single Leaflet Device Attachment During Transcatheter Edge-to-Edge Repair – How to Solve?

Presenter: Nicole Karam

October 24, 2023

Advertisement

TCT 68: Cardiac Implantable Electronic Device Lead-Related Tricuspid Regurgitation in Patients Presenting for Transcatheter Tricuspid Valve Interventions

TCT 597: Transcatheter Tricuspid Valve Replacement: From Preclinical to Early First-in-Human Experiences with the MonarQ Device

Can We Do Better? Next Generation LAAO Devices

TCT 614: Successful treatment of MAC patients with atrial fixation TMVR device: The AltaValve

No: The Transcatheter Devices Have Much Better Results

TCT 378: A novel miRNA nanocarrier for local device-based pharmacotherapy

Topic 4: Pulmonary Hypertension and Device Choice

Topic 1: Atrial Functional TR and Device Choice

TCT 846: First-in-Human Treatment of Severe Tricuspid Regurgitation using a novel Cross-Caval Heterotopic Device

A Novel Heterotopic Tricuspid Regurgitation Device for the Treatment of Tricuspid Regurgitation (Innoventric)

Other PFO Closure Devices and Techniques on the Horizon

TCT 888: Percutaneous catheter aspiration of native mitral valve endocarditis with brain protection using a new generation cerebral protection device

TCT 465: PROTEMBO C-TRIAL: Evaluation of a Novel Cerebral Embolic Protection Device in TAVR

TCT 945: Conform WhenThings are Unconformable: Novel Utilization of Combined Thrombectomy Devices to remove a Massive Organized Clot-in-Transit

PROs Alone in Non-Blinded Studies Shouldn’t Drive Device Approval

TCT 94: ProtEmbo: A Potential Shield Against Stroke and Cerebral Lesions in TAVR; Illustrated Using DW-MRI to Assess Device Efficacy

TCT 71: The Outcomes of Percutaneous Mitral Annuloplasty With the Carillon Device: Retrospective Analysis of Implanted vs Non-implanted Patients

TCT 70: Comparison of the Outcomes of Mitral Annuloplasty With the Carillon Device in Patients With Proportionate and Disproportionate Functional Mitral Regurgitation

More TRILUMINATE Patients Flesh Out Tricuspid TEER’s Impact

Case: Single Leaflet Device Attachment During Transcatheter Edge-to-Edge Repair – How to Solve?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content